Krystal Biotech
KRYS
KRYS
57 hedge funds and large institutions have $223M invested in Krystal Biotech in 2019 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 19 increasing their positions, 16 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3.51% more ownership
Funds ownership: 43.03% → 46.53% (+3.5%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
57
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$4.22M | |
| 2 | +$2.93M | |
| 3 | +$2.77M | |
| 4 |
O
OrbiMed
New York
|
+$1.95M |
| 5 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$1.6M |
Top Sellers
| 1 | -$2.96M | |
| 2 | -$979K | |
| 3 | -$650K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$400K |
| 5 |
Renaissance Technologies
New York
|
-$365K |